The Ecosystem: Illumina’s acquisition of Grail is a tremor, not an earthquake, for start-ups The Ecosystem: Illumina’s acquisition of Grail is a tremor, not an earthquake, for start-ups In the name of competition, the European Commission wants to stop the US DNA sequencing company from buying a US leader in applying DNA sequencing to novel cancer diagnostics. The view from the ground in Europe is that it may not matter so much 20 Sep 2022 News